Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microbiome Changes Following Laser and Chlorhexidine Cavity Disinfection
NCT06765330Not yet recruiting
- Sponsor
- Mersin University
- Start
- May 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Tegaderm CHG in dental caries (6 arms), sponsored by Mersin University. Primary endpoint: Microbiome Changes at 3 months. Planned start May 2025; status: not yet recruiting.
02
Drugs
Tegaderm CHG
03
Conditions
dental caries
Beyond the preview
Go deeper on NCT06765330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06765330.